-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

What Is the Role of Autologous Transplant for Lymphoma in the Current Era?

Program: Education Program
Session: Contemporary Therapy of Lymphoma
Saturday, December 5, 2015, 2:00 PM-3:30 PM
Chapin Theater (W320), Level 3 (Orange County Convention Center)
Sunday, December 6, 2015, 9:30 AM-11:00 AM
Hall D, Level 2 (Orange County Convention Center)

Patrick J. Stiff, MD

Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL

Disclosures: Stiff: Amgen: Research Funding ; Eisai: Research Funding ; Gilead: Consultancy , Honoraria , Research Funding ; Plasmacyclics: Consultancy , Honoraria , Research Funding ; Incyte: Consultancy , Honoraria , Research Funding ; Seattle Genetics: Consultancy , Honoraria , Research Funding ; Fate Therapeutics: Research Funding . Off Label Use: Ibrutinib: improve outcomes in lymphoma as part of transplant therapy.

See more of: Contemporary Therapy of Lymphoma
See more of: Education Program
<< Previous Presentation | Next Presentation >>